摘要
背景:肾脏疾病是一个严重影响人类健康的问题,但如何有效地治疗已建立的慢性肾脏病却缺乏重要的知识。不断增加的证据动物和临床研究表明,维生素D受体(VDR)激活对多种肾脏疾病有良好的治疗作用。 方法:对多种肾脏疾病(如IgA肾病、特发性肾病综合征、肾细胞癌)中VDR结构和功能的研究文献进行结构化检索。对多个数据库进行了Inoma、糖尿病肾病、狼疮肾炎和针对VDR的治疗。 结果:本研究包括177篇发表的研究成果。这些研究表明,VdR激活参与了肾损伤的保护作用。EY病的发病机制有多种,包括抑制RAS活化、抗炎、抑制肾纤维化形成、恢复线粒体功能、抑制自身免疫功能和人的免疫功能。AL细胞凋亡 结论:VDR是治疗肾脏疾病的理想靶点。增加我们对肾脏中vdr的理解是一个研究的沃土,并可能在战斗中提供有效的武器。对抗肾脏疾病。
关键词: 维生素D受体,肾损伤,肾小管上皮细胞,慢性肾脏疾病,肾性骨性营养不良,急性肾损伤。
Current Medicinal Chemistry
Title:Vitamin D Receptor: A Novel Therapeutic Target for Kidney Diseases
Volume: 25 Issue: 27
关键词: 维生素D受体,肾损伤,肾小管上皮细胞,慢性肾脏疾病,肾性骨性营养不良,急性肾损伤。
摘要: Background: Kidney disease is a serious problem that adversely affects human health, but critical knowledge is lacking on how to effectively treat established chronic kidney disease. Mounting evidence from animal and clinical studies has suggested that Vitamin D Receptor (VDR) activation has beneficial effects on various renal diseases.
Methods: A structured search of published research literature regarding VDR structure and function, VDR in various renal diseases (e.g., IgA nephropathy, idiopathic nephrotic syndrome, renal cell carcinoma, diabetic nephropathy, lupus nephritis) and therapies targeting VDR was performed for several databases.
Result: Included in this study are the results from 177 published research articles. Evidence from these papers indicates that VDR activation is involved in the protection against renal injury in kidney diseases by a variety of mechanisms, including suppression of RAS activation, anti-inflammation, inhibiting renal fibrogenesis, restoring mitochondrial function, suppression of autoimmunity and renal cell apoptosis.
Conclusion: VDR offers an attractive druggable target for renal diseases. Increasing our understanding of VDR in the kidney is a fertile area of research and may provide effective weapons in the fight against kidney diseases.
Export Options
About this article
Cite this article as:
Vitamin D Receptor: A Novel Therapeutic Target for Kidney Diseases, Current Medicinal Chemistry 2018; 25 (27) . https://dx.doi.org/10.2174/0929867325666180214122352
DOI https://dx.doi.org/10.2174/0929867325666180214122352 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bortezomib as an Antitumor Agent
Current Pharmaceutical Biotechnology The Implication of Platelet Activating Factor in Cancer Growth and Metastasis: Potent Beneficial Role of PAF-Inhibitors and Antioxidants
Infectious Disorders - Drug Targets Engagement of Renin-Angiotensin System in Prostate Cancer
Current Cancer Drug Targets Protein Microarrays: Technological Aspects, Applications and Intellectual Property
Recent Patents on Biotechnology Clinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver Diseases
Current Clinical Pharmacology Biologics: An Update and Challenge of Their Pharmacokinetics
Current Drug Metabolism Effects of Estrogen in the Brain: Is it a Neuroprotective Agent in Alzheimers Disease?
Current Aging Science Finding Relevant Genes Involved in the Cytotoxicity Mechanisms of Anticancer Biophores
Current Computer-Aided Drug Design Novel Drug-Induced Pulmonary Complications in Cancer Patients You Can Save Life!
Current Respiratory Medicine Reviews Serum Procalcitonin Levels in Febrile Patients with Systemic Autoimmune Diseases
Current Rheumatology Reviews In Vitro and In Vivo Sirolimus for Modulation of Allogeneic Hematopoietic Stem Cell Transplantation
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Ion Transport Across the Gallbladder Epithelium
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Targeting IAPs as An Approach to Anti-Cancer Therapy
Current Topics in Medicinal Chemistry A Novel Assay Platform for the Detection of Translation Modulators of Spermidine/ Spermine Acetyltransferase
Current Pharmaceutical Design Disposition of Flavonoids Impacts their Efficacy and Safety
Current Drug Metabolism Jade-1: its structure, regulation and functions in the renal cancer.
Current Molecular Medicine Microenvironmental Regulation of Cancer Stem Cell Phenotypes
Current Stem Cell Research & Therapy Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety
Recent Patents on Anti-Cancer Drug Discovery Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as a New Lead for Treating Breast and Ovarian Cancer
Current Drug Targets Functions of Antimicrobial Peptides in Vertebrates
Current Protein & Peptide Science